Many neurons express simultaneously two or more isotypes of glutamate receptors, so that pharmacological modulation of more than one receptor may be necessary to reveal the role of glutamate in mediating physiological processes. The present studies were aimed at evaluating involvement of endogenous glutamate in triggering plasma prolactin (PRL) and adrenocorticotropic hormone (ACTH) levels in response to three different stress stimuli (footshock, immobilization and ether stress). Blockade of glutamate receptor subtypes was achieved by the administration of the NMDA antagonist dizocilpine (MK-801, 0.2 mg/kg) and the selective AMPA antagonist GYKI 52466 (10 mg/kg). Rats were pretreated for 4–5 days and then exposed to stressful stimulation. Basal hormone levels were not affected by the antagonists. In male rats, combined, but not separate blockade of NMDA and AMPA/kainate subtypes of glutamate receptors prevented the rise in plasma PRL in response to footshock stress. In female rats, footshock-induced PRL release was inhibited even by separate blockade of NMDA receptors by dizocilpine, suggesting that the PRL system of females is more sensitive to the effect of NMDA antagonists than that of males. None of the treatments affected PRL release during immobilization or ether stress. Simultaneous blockade of NMDA and AMPA receptor subtypes resulted in a mild inhibition of immobilization-induced ACTH release without any effect on ACTH response to footshock or ether stress. The data suggest that involvement of glutamatergic pathways in neuroendocrine response during stress is selective for discrete stress stimuli and stress hormones. In addition a concerted action of glutamate on both NMDA and non-NMDA receptor subtypes is involved in the control of PRL release during footshock stress.

1.
Moghaddam B: Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: Comparison to hippocampus and basal ganglia. J Neurochem 1993;60:1650–1657.
2.
Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J: Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci 1987;10:273–279.
3.
Wilson R, Knobil E: Acute effects of N-methyl-DL-aspartate on the release of pituitary gonadotropins and prolactin in the female rhesus monkey. Brain Res 1982;248:177–179.
4.
Gay V, Plant T: N-methyl-D-aspartate elicits hypothalamic gonadotropin-releasing hormone release in prepubertal male rhesus monkeys (Macaca mulatta). Endocrinology 1987;120:2289–2296.
5.
Carlson HE, Migliette JT, Roginsky MS, Stegink LD: Stimulation of pituitary hormone secretion by neurotransmitter aminoacids in humans. Metabolism 1989;38:1179–1182.
6.
Pohl CR, Lee LR, Smith MS: Qualitative changes in luteinizing hormone and prolactin response to N-methyl-aspartic acid during lactation in the rat. Endocrinology 1989;124:1905–1911.
7.
Farah JM, Rao TS, Mick SJ, Coyne KE, Iyengar S: N-Methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat. Endocrinology 1991;128:1875–1880.
8.
Jezová D, Chautard T, Bartausz V, Jurcovicova J, Oliver C: Effect of N-methyl-D-aspartate receptor stimulation on the release of ACTH and other hormones; in Abstr 8th Gen Meet Eur Soc Neurochem, Leipzig, July, 1990.
9.
Jezova D, Oliver C, Jurcovicová J: Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid. Neuroendocrinology 1991;54:488–492.
10.
Chautard T, Boudouresque F, Guillaume V, Oliver C: Effect of excitatory amino acid on the hypothalamo-pituitary-adrenal axis in the rat during the stress-hyporesponsive period. Neuroendocrinology 1993;57:70–78.
11.
Yousef KA, Tepper PG, Molina PE, Abumrad NN, Lang CH: Differential control of glucoregulatory hormone response and glucose metabolism by NMDA and kainate. Brain Res 1994;634:131–140.
12.
Jezova D, Tokarev D, Rusnák M: Endogenous excitatory amino acids are involved in stress-induced adrenocorticotropin and catecholamine release. Neuroendocrinology 1995;62:326–332.
13.
Tokarev D, Jezová D: Effect of central administration of the non-NMDA receptor antagonist DNQX on ACTH and corticosterone release before and during immobilization stress. Methods Find Exp Clin Pharmacol 1997;19:323–328.
14.
Brann DW, Mahesh VB: Excitatory amino acids: Function and significance in reproduction and neuroendocrine regulation. Front Neuroendocrinol 1994;15:3–49.
15.
Brann DW: Glutamate: A major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology 1995;61:213–225.
16.
Soltis RP, Di Micco JA: Hypothalamic excitatory amino acid receptors mediate stress-induced tachycardia in rats. Am J Physiol 1992;262:R689–R697.
17.
Lodge D, Collingridge G: The pharmacology of excitatory amino acids. Trends Pharmacol Sci 1991 (special issue).
18.
Pechnick RN, George R, Poland RE: Characterization of the effects of acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat. Eur J Pharmacol 1989;164:257–263.
19.
Block F, Schwarz M: The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors. Eur J Pharmacol 1994;256:149–153.
20.
Iversen SD, Singh L, Oles RJ, Preston C, Tricklebank MD: Psychopharmacological profile of the N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801; in Domino EF, Kamenka J-M (eds): Sigma and Phencyclidine-Like Compounds as Molecular Probes in Biology. Ann Arbor, NPP Books, 1988, p 373.
21.
Yagi K, Onaka T: Chlordiazepoxide discriminates between the neural circuits mediating neuroendocrine responses to fear- and anxiety-producing stimuli in the rat. Neurosci Res 1996;24:151–158.
22.
Jezova D, Kvetnansky R, Kovacs K, Oprsalova Z, Vigas M, Makara GB: Insulin-induced hypoglycaemia activates the release of adrenocorticotropin predominantly via central and propranolol insensitive mechanism. Endocrinology 1987;120:409–415.
23.
Gilad GM, Gilad VH, Wyatt RJ, Tizabi Y: Region-selective stress-induced increase of glutamate uptake and release in rat forebrain. Brain Res 1990;525:335–338.
24.
Lowy MT, Gault L, Yamamoto BK: Adrenalectomy attenuates stress-induced elevation in extracellular glutamate concentration in the hippocampus. J Neurochem 1993;61:1957–1960.
25.
Sawchenko PE, Cunningham ET, Bittencourt JC, Chan RKW: Aminergic and peptidergic pathways subserving the stress response; in Kvetnansky R, McCarty R, Axelrod J (eds): Stress: Neuroendocrine and Molecular Approaches. New York, Gordon & Breach, 1992, pp 15–27.
26.
Bartanusz V, Aubry J-M, Pagliusi S, Jezová D, Baffi J, Kiss JZ: Stress-induced changes in messenger RNA levels of N-methyl-D-aspartate and AMPA receptor subunits in selected regions of the rat hippocampus and hypothalamus. Neuroscience 1995;66:247–252.
27.
Jezová D, Oprsalová Z, Farah J, Michel J, Koenig JI, Bartanusz V, Rusnák M: Action of N-methyl-D-aspartic acid (NMDA) on ACTH release: An effect inside or outside the blood-brain barrier; in Abstr 5th Symp on Catecholamines and Other Neurotransmitters in Stress, Smolenice, June, 1991, p 39.
28.
Barton AC, Demarest KT, Lookingland KJ, Moore KE: A sex difference in the stimulatory afferent regulation of tuberoinfundibular dopaminergic neuronal activity. Neuroendocrinology 1989;49:361–366.
29.
Gudelsky GA, Porter JC: Sex related differences in the release of dopamine into hypophysial portal blood. Endocrinology 1981;109:1394–1398.
30.
Gunet JW, Lookingland KJ, Moore KE: Effects of gonadal steroids on tuberoinfundibular and tuberohypophysial dopaminergic neuronal activity in male and female rats. Proc Soc Exp Biol Med 1986;183:48–53.
31.
Akinci MK, Johnston GA: Sex differences in acute swim stress-induced changes in the binding of MK-801 to the NMDA subclass of glutamate receptors in mouse forebrain. J Neurochem 1993;61:2290–2293.
32.
Herman JP, Cullinan WE: Neurocircuitry of stress: Central control of the hypothalamopituitary-adrenocortical axis. Trends Neurosci 1997;20:78–84.
33.
Lahat N, Miller A, Shtiller R, Touby E: Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 1993;47:35–40.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.